Analysis of the Frequency of the Toll-like 2 Gene Polymorphism in Leprosy

References (48)

1. 1 The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors [DOI]
2. 2 Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins [DOI]
3. 3 TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis [DOI]
4. 4 FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization [DOI]
5. 5 Activation and regulation of Toll-like receptors 2 and 1 in human leprosy [DOI]
6. 6 Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium tuberculosis Infection [DOI]
7. 7 A NewMycobacteriumSpecies Causing Diffuse Lepromatous Leprosy [DOI]
8. 8 Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients [DOI]
9. 9 Hanseníase no Brasil [DOI]
10. 10 Toll-Like Receptor 2 Arg677Trp Polymorphism Is Associated with Susceptibility to Tuberculosis in Tunisian Patients [DOI]
11. 11 A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis [DOI]
12. 12 BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control [DOI]
13. 13 Toll‐Like Receptor 2(TLR2)Polymorphisms Are Associated with Reversal Reaction in Leprosy [DOI]
14. 14 Multibacillary leprosy by population groups in Brazil: Lessons from an observational study [DOI]
15. 15 PROTECTIVE EFFICACY OF BCG AGAINST LEPROSY IN NORTHERN MALAWI [DOI]
16. 16 An association between single nucleotide polymorphisms within TLR and TREM-1 genes and infective endocarditis [DOI]
17. 17 The role of Toll-like receptors in combating mycobacteria [DOI]
18. 18 Strain background effects and genetic modifiers of hearing in mice [DOI]
19. 19 Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC [DOI]
20. 20 Gender and leprosy: case studies in Indonesia, Nigeria, Nepal and Brazil [DOI]
21. 21 Polymorphisms in TLR2 Are Associated with Increased Viral Shedding and Lesional Rate in Patients with Genital Herpes Simplex Virus Type 2 Infection [DOI]
22. 22 Toll-like receptors and antibody responses [DOI]
23. 23 Toll-like receptor 2 gene polymorphisms, pulmonary tuberculosis, and natural killer cell counts [DOI]
24. 24 Toll-like receptors, tumor necrosis factor–α, and interleukin-10 gene polymorphisms in risk of pulmonary tuberculosis and disease severity [DOI]
25. 25 Evaluation of Toll‐like receptor and adaptor molecule polymorphisms for susceptibility to tuberculosis in a Colombian population [DOI]
26. 26 Relationship between toll-like receptor 2 Arg677Trp and Arg753Gln and toll-like receptor 4 Asp299Gly polymorphisms and cytomegalovirus infection [DOI]
27. 27 TLR4 896A/G and TLR9 1174G/A polymorphisms are associated with the risk of infectious mononucleosis [DOI]
28. 28 Global leprosy statistics: a cause for pride, or frustration? [DOI]
29. 29 Características epidemiológicas da hanseníase nos idosos e comparação com outros grupos etários, Brasil (2016-2018) [DOI]
30. 30 Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents [DOI]
31. 31 Vacina BCG: eficácia e indicações da vacinação e da revacinação [DOI]
32. 32 Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case–control study in Yavatmal District, India [DOI]
33. 33 Características epidemiológicas e espaciais da hanseníase no Estado do Maranhão, Brasil, 2001-2012 [DOI]
34. 34 Polymorphisms in genes TLR1, 2 and 4 are associated with differential cytokine and chemokine serum production in patients with leprosy [DOI]
35. 35 Hanseníase em Rondônia: incidência e características dos casos notificados, 2001 a 2012 [DOI]
36. 36 Perfil epidemiológico da hanseníase no município de Guarulhos, SP [DOI]
37. 37 Leprosy: clinical and epidemiological study in patients above 60 years in Espírito Santo State - Brazil [DOI]
38. 38 Effect of BCG on the risk of leprosy in an endemic area: a case control study.
39. 39 Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon [DOI]
40. 40 Hanseníase: uma doença genética? [DOI]
41. 41 Protective effect of Bacillus Calmette Guerin (BCG) against leprosy: a population-based case-control study in Nagpur, India [DOI]
42. 42 Relation analysis of the occurrence of single nucleotide polymorphism of theDOCK9gene in keratoconus [DOI]
43. 43 Current Concepts in the Immunology of Leprosy [DOI]
44. 44 Leprosy and BCG in southern Vietnam [DOI]
45. 45 THE PATHOGENESIS OF LEPROSY:An Experimental Approach [DOI]
46. 46 Análise epidemiológica da hanseníase por sexo na Paraíba [DOI]
47. 47 BCG vaccination protects against leprosy in Venezuela: a case-control study.
48. 48 LEPROSY CASE DETECTION RATES BY AGE, SEX, AND POLAR TYPE UNDER LEPROSY CONTROL CONDITIONS [DOI]

Cited by 1

Related research

• The Nature and Complications of Acute Traumatic Cervical Spinal Cord Injury in a University Hospital in Nigeria — shares topic coverage
• Risk Factors Assessment of Zoonotic Anthrax among the People at Risk (PAR) in Selected Areas of Bangladesh — shares topic coverage
• Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
• Systematic Review of Visceral Leishmaniasis in Central Africa — shares topic coverage
• Administration of High-Risk Medication: A Hospital Based Prospective Study — shares topic coverage